Clinical Outcomes of Left Main Coronary Artery PCI With Rotational Atherectomy

• Published in: The American journal of cardiology Vol. 186; pp. 36 - 42
• Main Authors: Bouisset, Frédéric, Ribichini, Flavio, Bataille, Vincent, Reczuch, Krzysztof, Lhermusier, Thibault, Dobrzycki, Slawomir, Meyer-Gessner, Markus, Bressollette, Erwan, Zajdel, Wojciech, Faurie, Benjamin, Mezilis, Nikolaos, Palazuelos, Jorge, Vaquerizo, Beatriz, Ferenc, Miroslaw, Cayla, Guillaume, Barbato, Emanuele, Carrié, Didier
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2023; Elsevier Limited
• Subjects: Angioplasty; Atherectomy, Coronary - methods; Calcification; Catheters; Chi-square test; Clinical outcomes; Coronary Angiography - methods; Coronary artery; Coronary Artery Disease; Coronary vessels; Data collection; Ejection fraction; Heart; Heart surgery; Humans; Lesions; Mortality; Patients; Percutaneous Coronary Intervention - methods; Success; Treatment Outcome; Vascular Calcification - surgery; Veins & arteries
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2022.09.031

Data regarding rotational atherectomy percutaneous coronary intervention (RA PCI) angioplasty in the left main (LM) coronary artery are scarce, and mostly outdated. We aimed to describe clinical outcomes of RA PCI in LM. Patients requiring RA in 8 European countries and 19 centers were prospectively and consecutively included in the European registry of Cardiac Care of Calcified and Complex patients registry. In-hospital data collection and 1-year follow-up were performed for each patient. Between October 2016 and July 2018, 966 patients with complete data were included. Among them, 241 presented with an LM lesion, and 171 required an LM lesion preparation by RA. The latter, allocated to the LM-RA group, were compared with the 725 patients in the non–LM-RA group. Clinical success of the RA procedure was comparable in both groups, but in-hospital major adverse cardiac events were higher in the RA-LM group (7.6% vs 3.2%, adjusted p = 0.04), mainly driven by a higher in-hospital mortality rate (5.3 vs 0.3%, adjusted p = 0.005). At 1-year follow-up, mortality and major adverse cardiac event rates were comparable in both groups (12.9% vs 8.0%, adjusted p value: 0.821, and 15.8% vs 10.9%, adjusted p value: 0.329, respectively), but the rate of target vessel revascularization remained higher in the RA-LM group (5.3% vs 3.2%, adjusted p = 0.021). In conclusion, RA PCI is an efficient option for calcified LM lesions, providing acceptable outcomes regarding this population with high risk at 1 year, and yields comparable outcomes with RA PCI performed on non-LM lesions.